Corresponding author at: Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, Aligarh Muslim University, 202002, Uttar Pradesh, India.
was read the article
array:25 [ "pii" => "S225620871600016X" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.02.012" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "269" "copyright" => "Sociedad Colombiana de Anestesiología y Reanimación" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:97-104" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 961 "formatos" => array:3 [ "EPUB" => 91 "HTML" => 621 "PDF" => 249 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0120334716000162" "issn" => "01203347" "doi" => "10.1016/j.rca.2016.01.006" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "269" "copyright" => "Sociedad Colombiana de Anestesiología y Reanimación" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:97-104" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2298 "formatos" => array:3 [ "EPUB" => 94 "HTML" => 1819 "PDF" => 385 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Investigación científica y tecnológica</span>" "titulo" => "Levobupivacaína o ropivacaína: un ensayo aleatorizado doble ciego controlado con dosis equipotentes en la anestesia espinal" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "97" "paginaFinal" => "104" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Levobupivacaine or ropivacaine: A randomised double blind controlled trial using equipotent doses in spinal anaesthesia" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 919 "Ancho" => 1639 "Tamanyo" => 101009 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Características del bloqueo.</p> <p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Fuente: autores.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Manazir Athar, Syed Moied Ahmed, Shahna Ali, Kashmiri Doley, Ankur Varshney, Mohd. Masood Hussain Siddiqi" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Manazir" "apellidos" => "Athar" ] 1 => array:2 [ "nombre" => "Syed Moied" "apellidos" => "Ahmed" ] 2 => array:2 [ "nombre" => "Shahna" "apellidos" => "Ali" ] 3 => array:2 [ "nombre" => "Kashmiri" "apellidos" => "Doley" ] 4 => array:2 [ "nombre" => "Ankur" "apellidos" => "Varshney" ] 5 => array:2 [ "nombre" => "Mohd. Masood Hussain" "apellidos" => "Siddiqi" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S225620871600016X" "doi" => "10.1016/j.rcae.2016.02.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225620871600016X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716000162?idApp=UINPBA00004N" "url" => "/01203347/0000004400000002/v1_201604250003/S0120334716000162/v1_201604250003/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2256208716000043" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.02.002" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "257" "copyright" => "Sociedad Colombiana de Anestesiología y Reanimación" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:105-13" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1342 "formatos" => array:3 [ "EPUB" => 95 "HTML" => 1021 "PDF" => 226 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>" "titulo" => "Design and performance evaluation of the “iTIVA” algorithm for manual infusion of intravenous anesthetics based on effect-site target" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "105" "paginaFinal" => "113" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Diseño y evaluacion del desempeño del algoritmo “iTIVA” para la administración manual de anestesicos intravenosos según objetivo en sitio efecto" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 3527 "Ancho" => 2667 "Tamanyo" => 519339 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Desired and predicted plasma and effect-site concentrations organized into desired targets for remifentanil. <span class="elsevierStyleItalic">Source</span>: Authors</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "David Eduardo Ramírez, José Andrés Calvache" "autores" => array:2 [ 0 => array:2 [ "nombre" => "David Eduardo" "apellidos" => "Ramírez" ] 1 => array:2 [ "nombre" => "José Andrés" "apellidos" => "Calvache" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0120334716000046" "doi" => "10.1016/j.rca.2016.02.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716000046?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716000043?idApp=UINPBA00004N" "url" => "/22562087/0000004400000002/v1_201604260026/S2256208716000043/v1_201604260026/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2256208716300037" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.03.009" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "279" "copyright" => "Sociedad Colombiana de Anestesiología y Reanimación" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:89-96" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1133 "formatos" => array:3 [ "EPUB" => 98 "HTML" => 708 "PDF" => 327 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>" "titulo" => "Etilefrine vs. phenylephrine for hypotension during spinal anesthesia for cesarean section: Multicenter, randomized, double blind controlled clinical trial" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "89" "paginaFinal" => "96" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Etilefrina vs fenilefrina en hipotensión por anestesia espinal para cesárea: ensayo clínico multicéntrico, controlado, aleatorizado y doble ciego" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1398 "Ancho" => 1554 "Tamanyo" => 157984 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Systolic Blood Pressure comparison between both groups. SBP: Systolic Blood Pressure.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Diana Bolaños-Arboleda, Nelson Javier Fonseca-Ruiz, Nury Isabel Socha-García, Edward García-Peñuela, Germán Monsalve-Mejía" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Diana" "apellidos" => "Bolaños-Arboleda" ] 1 => array:2 [ "nombre" => "Nelson Javier" "apellidos" => "Fonseca-Ruiz" ] 2 => array:2 [ "nombre" => "Nury Isabel" "apellidos" => "Socha-García" ] 3 => array:2 [ "nombre" => "Edward" "apellidos" => "García-Peñuela" ] 4 => array:2 [ "nombre" => "Germán" "apellidos" => "Monsalve-Mejía" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0120334716300077" "doi" => "10.1016/j.rca.2016.01.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300077?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300037?idApp=UINPBA00004N" "url" => "/22562087/0000004400000002/v1_201604260026/S2256208716300037/v1_201604260026/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>" "titulo" => "Levobupivacaine or ropivacaine: A randomised double blind controlled trial using equipotent doses in spinal anaesthesia" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "97" "paginaFinal" => "104" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Manazir Athar, Syed Moied Ahmed, Shahna Ali, Kashmiri Doley, Ankur Varshney, Mohd. Masood Hussain Siddiqi" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Manazir" "apellidos" => "Athar" ] 1 => array:4 [ "nombre" => "Syed Moied" "apellidos" => "Ahmed" "email" => array:1 [ 0 => "sma99@rediffmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:2 [ "nombre" => "Shahna" "apellidos" => "Ali" ] 3 => array:2 [ "nombre" => "Kashmiri" "apellidos" => "Doley" ] 4 => array:2 [ "nombre" => "Ankur" "apellidos" => "Varshney" ] 5 => array:2 [ "nombre" => "Mohd. Masood Hussain" "apellidos" => "Siddiqi" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, Aligarh Muslim University, UP, India" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author at</span>: Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, Aligarh Muslim University, 202002, Uttar Pradesh, India." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Levobupivacaína o ropivacaína: un ensayo aleatorio doble ciego controlado con dosis equipotentes en la anestesia espinal" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0025" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 948 "Ancho" => 1578 "Tamanyo" => 96594 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Block characteristics.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Traditionally, bupivacaine has been the drug of choice for the subarachnoid block. However, significantly long duration of action delays recovery of motor function and prolongs post-anaesthesia care unit stay. In addition, several studies have shown that bupivacaine produces higher neurological and cardiac toxicity compared to other local anaesthetics.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">1</span></a> The problems associated with the toxicity of racemic bupivacaine triggered the development of alternative suitable ‘single enantiomeric’ local anaesthetic agents with low cardiac and CNS toxicity. Levobupivacaine and Ropivacaine are two relatively new amide local anaesthetic agents that have been produced in order to address the issues of bupivacaine toxicity.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Levobupivacaine is a high potency, long-acting local anaesthetic with a relatively slow onset of action.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> It has a lower propensity to block inactivated sodium and potassium channels along with faster rate of dissociation compared to its racemic form.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">3</span></a> The majority of in vitro, in vivo and human pharmacodynamic studies of nerve block indicate that levobupivacaine has similar potency, yet lower risk of cardiovascular and CNS toxicity than bupivacaine.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">4</span></a> So, having a higher threshold for cardiac and neurotoxicity compared to racemic bupivacaine, anaesthetists feel safer working with levobupivacaine<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">5</span></a> and has the potential to replace bupivacaine as the standard drug.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">6</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Ropivacaine is the ‘S’ isomer of the propyl analogue of bupivacaine with longer duration of action, low lipid solubility, low potency and low cardiovascular and CNS toxicity.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">7</span></a> Ropivacaine blocks nerve fibres involved in pain transmission (Aδ and C fibres) to a greater degree than those controlling motor function (Aβ fibres).<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">8</span></a> Therefore, ropivacaine has been found to induce less intense motor blockade than bupivacaine. Hence, its comparatively shorter duration, faster recovery of motor function and lower toxicity profile have been identified as a potential benefit for surgery of intermediate duration as well as for ambulatory surgery in day care surgical units.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In the present era of evidence-based medicine, each step of our management is thoroughly evaluated by properly controlled, peer-reviewed medical research, and subarachnoid block is not an exception. The concept of a single shot with bupivacaine can do all is now questioned and necessitate the judicious use of safer substitutes. As of Casati et al.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">9</span></a> theoretical as well as experimental differences do exist in toxicology and clinical profiles due to different anaesthetic potencies of these isomeric forms of bupivacaine, but reflections of these characteristics into clinical practice have not been evident so far. So, we have to explore the typical characteristics and potential uses of these newer drugs. Many studies have been done to compare various forms of bupivacaine, ropivacaine and levobupivacaine. However, most of them have used low doses which may be inadequate for hip surgeries.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">10</span></a> Furthermore, they have generally used hyperbaric forms<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11,12</span></a> and potency ratio between levobupivacaine and ropivacaine was not taken into consideration.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">13</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Therefore, this study was conducted to compare the efficacy and characteristics of isobaric forms of intrathecal levobupivacaine 0.5% with ropivacaine 0.75% in equipotent doses for lower limb orthopaedic surgery.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Methodology</span><p id="par0030" class="elsevierStylePara elsevierViewall">Following approval by the Institutional Ethics Committee [(Ref. No. D1303/FM) and Clinical Trial Registry No. (<a id="intr0015" class="elsevierStyleInterRef" href="https://clinicaltrials.gov/NCT02201784">NCT02201784</a>)] and written informed consent, this prospective, randomised, double-blind, controlled, equivalence trial was conducted on sixty ASA grade I/II patients of either sex, aged between 18 and 60 years undergoing spinal anaesthesia for lower limb orthopaedic surgery. Patients with contraindication for spinal anaesthesia, known allergy to local anaesthetic drugs and patients having h/o diabetes, neurological or musculoskeletal diseases that could make our technique difficult were excluded. The patients were randomly divided into two groups of 30 each (group L and group R) by computer-generated randomisation (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Patients in group L received 3<span class="elsevierStyleHsp" style=""></span>ml levobupivacaine 5<span class="elsevierStyleHsp" style=""></span>mg/ml (15<span class="elsevierStyleHsp" style=""></span>mg of LEVO-ANAWIN<span class="elsevierStyleSup">®</span> 0.5% Neon Laboratories Ltd.) while in group R received 3<span class="elsevierStyleHsp" style=""></span>ml ropivacaine 7.5<span class="elsevierStyleHsp" style=""></span>mg/ml (22.5<span class="elsevierStyleHsp" style=""></span>mg of ROPIN<span class="elsevierStyleSup">®</span> 0.75% Neon Laboratories Ltd.). All drugs were loaded by an anaesthetist who did not have any involvement in further patient assessment while another anaesthetist administered anaesthesia and assessed all patients. Patients had standard monitoring including electrocardiography, pulse oximetry and non-invasive blood pressure monitoring (NIBP). Baseline heart rate (HR), NIBP and arterial oxygen saturation (SpO<span class="elsevierStyleInf">2</span>) were measured. All patients received oxygen via Hudson mask at the rate of 6<span class="elsevierStyleHsp" style=""></span>l/min until the surgery ends. Intravenous (IV) access was secured, patients were premedicated with i.v. ondansetron 0.1<span class="elsevierStyleHsp" style=""></span>mg/kg body weight and preloading done with lactated Ringer's (LR) solution 15<span class="elsevierStyleHsp" style=""></span>ml/kg body weight. Under strict aseptic precautions, skin was infiltrated with lidocaine 2% and lumbar puncture was performed in the sitting position with a 25-G Quincke spinal needle (Becton Dickinson, Madrid, Spain), using a midline approach at the L<span class="elsevierStyleInf">3–4</span> intervertebral space. Correct needle placement was identified by free flow of CSF and confirmed by aspiration and reinjection of CSF before and after the administration of the study drug solution. The study drug was injected over 20<span class="elsevierStyleHsp" style=""></span>s. After the injection of the spinal medication, the patients were placed supine immediately, the time of which was recorded as ‘zero’. The level of sensory block was assessed every 5<span class="elsevierStyleHsp" style=""></span>min till the loss of sensation to pinprick, using a 22-guage hypodermic needle with 2<span class="elsevierStyleHsp" style=""></span>mm protrusion through the guard. Assessments continued at 30<span class="elsevierStyleHsp" style=""></span>min intervals following the completion of surgery until normal sensation returned. After confirming the loss of sensation at T<span class="elsevierStyleInf">10</span> dermatome in comparison to C<span class="elsevierStyleInf">5–6</span> dermatome, patients were given i.v. midazolam 0.03<span class="elsevierStyleHsp" style=""></span>mg/kg body weight and surgeons were allowed to proceed for the surgery. Inability to achieve T<span class="elsevierStyleInf">10</span> sensory level within 30<span class="elsevierStyleHsp" style=""></span>min was considered as ‘Failure’. These patients were administered general anaesthesia. They were not included for analysis but only reported as total number of failures according to per protocol analysis. Motor block in the lower limbs was graded according to the modified Bromage scale<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">14</span></a> (Grade 0<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>No motor block, Grade 1<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>Inability to raise extended leg, able to move knees and feet, Grade 2<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>Inability to raise extended leg and move knee, able to move feet, Grade 3<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>Complete motor block of the lower limbs). Thereafter, it was performed every 5<span class="elsevierStyleHsp" style=""></span>min till the attainment of MB grade 3 followed by every 30<span class="elsevierStyleHsp" style=""></span>min until complete recovery (MB grade 0). HR, NIBP and SpO<span class="elsevierStyleInf">2</span> was recorded before induction, every 3<span class="elsevierStyleHsp" style=""></span>min till 15<span class="elsevierStyleHsp" style=""></span>min, then, every 15<span class="elsevierStyleHsp" style=""></span>min until discharge from the recovery room. Hypotension was defined as systolic BP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>90<span class="elsevierStyleHsp" style=""></span>mmHg and was treated with inj. mephenteramine of 6<span class="elsevierStyleHsp" style=""></span>mg i.v bolus and fluids. Bradycardia was defined as HR<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>beats/min and treated with i.v. atropine of 0.5<span class="elsevierStyleHsp" style=""></span>mg, if symptomatic. For assessment of the onset of anaesthesia, the time for sensory block to develop to T<span class="elsevierStyleInf">10</span>, maximum block height and time to achieve maximum height were noted. To assess the duration of the sensory block, time for regression to L<span class="elsevierStyleInf">1</span> and duration of analgesia (primary outcome) were compared. Time to achieve maximum motor block, duration of motor block along with any side effects were also noted.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Statistical analysis</span><p id="par0035" class="elsevierStylePara elsevierViewall">Power analysis estimated that a sample size of 30 patients per group would yield 95% power for testing the hypothesis at equivalence margin of 30-min difference in mean time to first analgesic requirement (PS Power and Sample Size Calculator-Version 3.0.43; Dupont WD, Plummer WD). The Type I error probability associated with this test, for the null hypothesis that levobupivacaine and ropivacaine in equipotent doses are similar in terms of duration of analgesia was <span class="elsevierStyleItalic">α</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.05 (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 2</a>). Statistical analysis was performed using Excel 2013 (Microsoft, Redmond, VA), SPSS software (Version 19, SPSS Inc., USA) and Graph Pad Prism 5.00 (Graph Pad Software, San Diego, CA). Data are presented as mean (±SD), median (range), or frequencies (%) as appropriate. Group demographic data and adverse events were compared using unpaired <span class="elsevierStyleItalic">t</span>-test or chi-square (<span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span>) test, whichever applicable. Comparison of block characteristics, duration of analgesia and haemodynamics were made using unpaired <span class="elsevierStyleItalic">t</span>-test. To compare intragroup variations from baseline, one-way ANOVA with Dunnett's multiple comparisons tests was used. A <span class="elsevierStyleItalic">p</span>-value of <0.05 was considered statistically significant.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><p id="par0040" class="elsevierStylePara elsevierViewall">There were no significant differences between the two groups with respect to age, sex, weight, ASA grade or duration of surgery (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Anaesthesia was successful in all patients except two failures in group L. Onset of anaesthesia to T<span class="elsevierStyleInf">10</span> was 7.33<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.49<span class="elsevierStyleHsp" style=""></span>min in group R and 13.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.86<span class="elsevierStyleHsp" style=""></span>min in group L (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001). The median (range) maximum height achieved in terms of dermatomes in group R was T<span class="elsevierStyleInf">7</span> (T<span class="elsevierStyleInf">5</span>–T<span class="elsevierStyleInf">10</span>) while in group L was T<span class="elsevierStyleInf">7</span> (T<span class="elsevierStyleInf">4</span>–T<span class="elsevierStyleInf">10</span>). The time to reach maximum height was shorter in group R (13.17<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.02<span class="elsevierStyleHsp" style=""></span>min) as compared to group L (20.33<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.31<span class="elsevierStyleHsp" style=""></span>min) with a <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001 (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>, <a class="elsevierStyleCrossRef" href="#fig0025">Fig. 3</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><elsevierMultimedia ident="fig0025"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">The time to modified Bromage 3 (MB-3) grade was 7.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.84<span class="elsevierStyleHsp" style=""></span>min in group R and 12.17<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.09<span class="elsevierStyleHsp" style=""></span>min in group L with <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001. Levobupivacaine produced significantly longer duration of motor block (290.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.67<span class="elsevierStyleHsp" style=""></span>min) compared to ropivacaine (222.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>23.00<span class="elsevierStyleHsp" style=""></span>min), <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001. Time for regression of sensory block to L1 was longer in the group L than group R (251.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>33.12<span class="elsevierStyleHsp" style=""></span>min versus 191.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>22.86<span class="elsevierStyleHsp" style=""></span>min; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001). Duration of analgesia was also significantly longer in group L (309.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>36.45) than group R (249.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>22.83), <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Baseline haemodynamic parameters were comparable in both the groups. The mean MAP decreased significantly in both the groups compared to baseline/preoperative values (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05) but overall incidence of hypotension was not significantly different (<a class="elsevierStyleCrossRef" href="#fig0035">Fig. 4</a>a). Furthermore, it was transient (30<span class="elsevierStyleHsp" style=""></span>min) in ropivacaine group compared to levobupivacaine which was sustained (100<span class="elsevierStyleHsp" style=""></span>min). There were no significant differences between the two groups with respect to PR and SpO<span class="elsevierStyleInf">2</span> (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>0.05) (<a class="elsevierStyleCrossRef" href="#fig0035">Fig. 4</a>b and c).</p><elsevierMultimedia ident="fig0035"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">No incidence of Post Dural Puncture Headache (PDPH) or any other significant adverse effect was observed in either group (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). Hypotension was the most common side effect seen in both the groups, however, total amount of mephentermine used was significantly not different (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>0.05). Bradycardia occurred during intra-op period in 2 patients of each group.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Discussion</span><p id="par0060" class="elsevierStylePara elsevierViewall">In our study isobaric levobupivacaine showed significantly slower onset of sensory and motor block but with prolonged duration of analgesia compared to ropivacaine.</p><p id="par0065" class="elsevierStylePara elsevierViewall">No significant differences in patient characteristics and baseline haemodynamic parameters were observed between the two groups.</p><p id="par0070" class="elsevierStylePara elsevierViewall">Levobupivacaine and ropivacaine have been produced in order to address the issues of bupivacaine toxicity.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">1,15</span></a> Several studies have been undertaken in the past to evaluate the clinical efficacy and toxicology of these local anaesthetics in different dosage and baricity. Most of these clinical studies suggested that levobupivacaine was slightly less potent than bupivacaine but more potent than ropivacaine.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">16</span></a> Higher potency of levobupivacaine than ropivacaine could partly be explained by its greater lipid solubility and formulation<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">17</span></a> which underestimates the active molecules by 12.6% than its racemate.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">18</span></a> However, many recent studies<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">19,20</span></a> have found greater than 30% difference in potency which implies that levobupivacaine is actually more potent than ropivacaine. Its potency compared to ropivacaine remained inconsistent and varied from 1 to 1.67.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">17</span></a> So, based on the above facts and various previous studies,<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">7,19,21,22</span></a> we assumed levobupivacaine to be 1.5 times more potent than ropivacaine.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Previous authors have used different doses (5–17.5<span class="elsevierStyleHsp" style=""></span>mg) of levobupivacaine.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11,12,23,24</span></a> Taking into consideration the previous studies,<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11–13</span></a> MLAC and potency ratio we have used levobupivacaine 15<span class="elsevierStyleHsp" style=""></span>mg (5<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>ml<span class="elsevierStyleSup">−1</span>) to compare ropivacaine 22.5<span class="elsevierStyleHsp" style=""></span>mg (7.5<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>ml<span class="elsevierStyleSup">−1</span>), so as to achieve adequate sensory and motor block for most of the orthopaedic procedures.</p><p id="par0080" class="elsevierStylePara elsevierViewall">There is gross variation in the findings of various authors regarding sensory block onset time. According to some authors, there is no significant difference in onset time.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11–13,24</span></a> Contrary to this, some are of the opinion that there is significant difference in the onset time of two drugs.<a class="elsevierStyleCrossRefs" href="#bib0295"><span class="elsevierStyleSup">23,25,26</span></a> However, in the present study, ropivacaine achieved sensory level of T<span class="elsevierStyleInf">10</span> significantly faster than levobupivacaine consistent with the past researches.<a class="elsevierStyleCrossRefs" href="#bib0295"><span class="elsevierStyleSup">23,25,26</span></a> The variations in the finding of these studies could be due to sample size, demographic profile, methodology, drug dose and baricity. Cuvas et al.<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">27</span></a> has only taken elderly (>60 yrs) males while Sananslip et al.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">28</span></a> recruited females posted for gynaecological surgery.</p><p id="par0085" class="elsevierStylePara elsevierViewall">In the present study, both groups achieved the median dermatomal height of T<span class="elsevierStyleInf">7</span> but levobupivacaine took longer time to achieve maximum block level than ropivacaine. Furthermore, levobupivacaine (T<span class="elsevierStyleInf">4</span>–T<span class="elsevierStyleInf">10</span>) showed slightly greater variability compared to ropivacaine (T<span class="elsevierStyleInf">5</span>–T<span class="elsevierStyleInf">10</span>). According to most of the authors,<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">12,21,23,26–29</span></a> median height attained was in the range of T<span class="elsevierStyleInf">8</span>–T<span class="elsevierStyleInf">9</span> with similar dosing and technique. Nevertheless, few authors<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11,12</span></a> obtained varied results which may be attributed to different doses and baricity of the ropivacaine used in their study.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Similar to the sensory blockade, ropivacaine also showed faster onset of motor blockade compared to levobupivacaine. However, Khaw et al.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">30</span></a> used a measured isobaric preparation of ropivacaine for spinal anaesthesia in right lateral position administered over 60<span class="elsevierStyleHsp" style=""></span>s did not find any significant difference. As we have not measured the specific gravity of the drug in our study, taking into consideration the fact that bupivacaine and ropivacaine are hypobaric at 37<span class="elsevierStyleHsp" style=""></span>°C,<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">31</span></a> it can be assumed that the hypobaric nature of our drug, sitting position<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">32,33</span></a> and comparatively faster rate of injection<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">29</span></a> has resulted in quicker onset of motor blockade.</p><p id="par0095" class="elsevierStylePara elsevierViewall">In our study, sensory (L<span class="elsevierStyleInf">1</span>) and motor regression of ropivacaine was comparatively faster than levobupivacaine. Various authors in the past obtained similar results with ropivacaine showing faster sensory<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">11,24,25</span></a> and motor recovery.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">13,23,27</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">Ropivacaine and levobupivacaine, apart from being slightly different in potencies, are assumed to be almost similar in clinical hands.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">9</span></a> But the present study showed that even at equipotent doses of 1.5:1 (Ropi:Levo), ropivacaine offer significantly shorter duration of analgesia compared to levobupivacaine. This was similar to the findings of previous authors who showed early regression of ropivacaine as compared to levobupivacaine.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">12,23,34</span></a> However, Gautier et al.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">35</span></a> documented no difference while comparing 12<span class="elsevierStyleHsp" style=""></span>mg ropivacaine with 8<span class="elsevierStyleHsp" style=""></span>mg levobupivacaine in Caesarean section. Different pharmacodynamic response due to lower dose and different study population seems to be the most reasonable explanation for this discrepancy.</p><p id="par0105" class="elsevierStylePara elsevierViewall">Decrease in MAP and PR are two most frequently encountered complications of neuraxial blocks. In our study, it was observed that fall in BP was transient in ropivacaine group but sustained in levobupivacaine group. In spite of this, there was no significant difference in the overall incidence of hypotension and these were promptly treated without any serious consequences. Further, the total mephentermine dose required in both the groups were comparable (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>0.05). However, the higher incidence of transient hypotension seen with ropivacaine could arise due to quicker attainment of maximum height of block in comparison to levobupivacaine resulting in fall blood pressure. This was in accordance with the opinion of Carpenter et al.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">36</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">Extreme care and vigilance were taken to avoid biases by making the study randomised and double blind. However, biases and limitations often creep during research and this study is not an exception. Study design might have led certain degree of biases to sneak in as we used per protocol analysis. An important limitation of our study was that we did not measure the specific gravity of either of the drug. Maintenance of temperature could be a problem in tropical countries which could have influenced the overall results.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">30</span></a> Besides, higher sodium concentration and osmolality of levobupivacaine further increases its density. The quality of anaesthesia was also not measured in the study.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Conclusion</span><p id="par0115" class="elsevierStylePara elsevierViewall">We, therefore, conclude that isobaric levobupivacaine and ropivacaine doses used in the study produce adequate anaesthesia and analgesia for lower limb orthopaedic surgery without any serious side effects. Levobupivacaine produces significantly longer duration of analgesia than ropivacaine when used in a ratio of 0.6:1. Hence, drugs should be used taking into consideration the condition of patient, nature and duration of surgery. Efficacy, toxicity and haemodynamic profile make ropivacaine suitable agent for day care and other surgeries with low threshold for hypotension, while levobupivacaine can be a suitable agent for prolonged surgeries.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Funding</span><p id="par0120" class="elsevierStylePara elsevierViewall">None.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflicts of interest</span><p id="par0125" class="elsevierStylePara elsevierViewall">None declared.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres631174" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec644027" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres631173" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusión" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec644026" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Methodology" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Statistical analysis" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Results" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Discussion" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Conclusion" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Funding" ] 11 => array:2 [ "identificador" => "sec0040" "titulo" => "Conflicts of interest" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-07-05" "fechaAceptado" => "2016-01-28" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec644027" "palabras" => array:5 [ 0 => "Anesthesia, spinal" 1 => "Anesthetics, local" 2 => "Hemodynamics" 3 => "Bupivacaine" 4 => "Anesthesia" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec644026" "palabras" => array:5 [ 0 => "Anestesia espinal" 1 => "Anestésicos locales" 2 => "Hemodinámica" 3 => "Bupivacaina" 4 => "Anestesia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Levobupivacaine and ropivacaine are relatively new local anaesthetics developed in order to address the issue of bupivacaine toxicity. Although certain differences do exist between their pharmacological profiles, its clinical relevance at equipotent doses is not evident so far.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To compare the efficacy and characteristics of equipotent doses of intrathecal levobupivacaine with ropivacaine.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methodology</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Sixty ASA grade I/II patients of 18–60 years, either sex posted for lower limb orthopaedic surgery under spinal anaesthesia were randomly given either 15<span class="elsevierStyleHsp" style=""></span>mg levobupivacaine or 22.5<span class="elsevierStyleHsp" style=""></span>mg ropivacaine. Sensory and motor block, haemodynamic characteristics, as well as any side effects, were recorded.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Onset of sensory block to T<span class="elsevierStyleInf">10</span> was more rapid in group R than group L, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001. The median (range) height achieved in group R was T7 (T5–T10) while in group L was T7 (T4–T10). Time to reach maximum height and time to modified Bromage grade 3 was shorter in group R as compared to group L, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001. Levobupivacaine produced significantly longer (290.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.67) duration of motor block compared to ropivacaine (222.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>23.00). Duration of analgesia was significantly longer in group L (309.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>36.45) than group R (249.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>22.83). No serious adverse effects were recorded.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusion</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Levobupivacaine produces significantly longer duration of analgesia than ropivacaine when used in a ratio of 0.6:1. Efficacy, toxicity and haemodynamic profile make ropivacaine suitable agent for surgeries with low threshold for hypotension.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducción</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La levobupivacaína y la ropivacaína son anestésicos locales relativamente nuevos, desarrollados con el fin de abordar la cuestión de la toxicidad de la bupivacaína. Aunque existen ciertas diferencias entre sus perfiles farmacológicos, su relevancia clínica en dosis equipotentes no es evidente hasta ahora.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivo</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Comparar la eficacia y las características de las dosis equipotentes de levobupivacaína por vía intratecal con las de ropivacaína.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Metodología</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">A Sesenta pacientes de grado ASA I/II de 18 a 60 años y de ambos sexos, programados para cirugía ortopédica del miembro inferior bajo anestesia espinal, se les dio al azar o bien 15<span class="elsevierStyleHsp" style=""></span>mg de levobupivacaína o 22,5<span class="elsevierStyleHsp" style=""></span>mg de ropivacaína. El bloqueo motor, el bloqueo sensorial, las características hemodinámicas y cualquier otro efecto secundario fueron registrados.</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">El inicio del bloqueo sensorial en T10 fue más rápido en el grupo R que en el grupo L, p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001. El nivel mediano (rango) alcanzado en el grupo R fue T7 (T5-T10), mientras en el grupo L fue T7 (T4-T10). El tiempo para alcanzar el nivel máximo y para alcanzar un grado 3 en la escala de Bromage fue más breve en el grupo R en comparación con el grupo L, p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001. La levobupivacaína produce una duración significativamente más larga (290.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.67) del bloqueo motor que la ropivacaína (222.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>23.00). La duración de la analgesia fue significativamente más larga en el grupo L (309.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>36.45) que en el grupo R. No se registraron efectos adversos graves.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusión</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">La levobupivacaína produce una duración de la analgesia significativamente más larga que la ropivacaína cuando se utiliza en una proporción de 0,6:1. La eficacia, toxicidad y perfil hemodinámico hacen de la ropivacaína un agente adecuado para cirugías con un umbral bajo de hipotensión.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusión" ] ] ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Athar M, Ahmed SM, Ali S, Doley K, Varshney A, Siddiqi MMH. Levobupivacaína o ropivacaína: un ensayo aleatorio doble ciego controlado con dosis equipotentes en la anestesia espinal. Rev Colomb Anestesiol. 2016;44:97–104.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Clinical Trial Registry Number: <a class="elsevierStyleInterRef" id="intr0010" href="ctgov:NCT02201784">NCT02201784</a>.</p>" ] ] "multimedia" => array:7 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1669 "Ancho" => 2353 "Tamanyo" => 168013 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">CONSORT flow diagram.</p>" ] ] 1 => array:8 [ "identificador" => "fig0015" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 693 "Ancho" => 1590 "Tamanyo" => 77615 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Sample size versus power graph for the study.</p>" ] ] 2 => array:8 [ "identificador" => "fig0025" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 948 "Ancho" => 1578 "Tamanyo" => 96594 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Block characteristics.</p>" ] ] 3 => array:8 [ "identificador" => "fig0035" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "<span class="elsevierStyleItalic">Source</span>: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2913 "Ancho" => 1569 "Tamanyo" => 259758 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">(a) Mean arterial pressure variation with time. (b) Pulse rate variation with time. (c) SpO<span class="elsevierStyleInf">2</span> variation with time.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">n</span>, number of patients; M:F, male:female; min, minutes; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>0.05 is considered significant.</p><p id="spar0105" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>: Authors.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group L (<span class="elsevierStyleItalic">n</span>) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group R (<span class="elsevierStyleItalic">n</span>) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">38<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>17 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>16 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.51 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sex (M:F) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24:6 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">23:7 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.99 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Weight \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">53.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>9.44 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">57.17<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.65 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.12 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ASA grade I/II \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24/6 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24/6 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.00 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duration of surgery (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">108<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>39.47 (28) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">93<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>25.35 (30) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.09 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1035466.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Patient characteristics.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">n</span>, number of patients; “T” is dermatomal level; min, minutes; data are expressed as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD or median (range); <span class="elsevierStyleItalic">p</span>-value <0.05 is considered significant.</p><p id="spar0110" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>: Authors.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group L (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>28) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group R (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>30) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Time to achieve sensory block at T<span class="elsevierStyleInf">10</span> (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.94 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.33<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.54 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Median maximum level of sensory blockade (range) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">T<span class="elsevierStyleInf">7</span> (T<span class="elsevierStyleInf">4</span>–T<span class="elsevierStyleInf">10</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">T<span class="elsevierStyleInf">7</span> (T<span class="elsevierStyleInf">5</span>–T<span class="elsevierStyleInf">10</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Time to maximum cephalic spread of sensory block (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20.33<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.31 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.17<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.02 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Recovery to L<span class="elsevierStyleInf">1</span> (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">251.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>33.12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">191.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>22.86 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duration of analgesia (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">309.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>36.45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">249.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>22.83 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Onset of motor block to Bromage 3 (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.17<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.09 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.83<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.84 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duration of motor block (min) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">290.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">222.50<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>23.00 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1035464.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Block characteristics.</p>" ] ] 6 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">n</span>, number of patients; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>0.05 is considered significant.</p><p id="spar0115" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>: Authors.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group L (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>28) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Group R (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>30) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nausea/vomiting \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4/0 (14/%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2/0 (7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hypotension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (25%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10 (33%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.57 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Bradycardia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.99 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Shivering \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (11%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (17%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.71 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1035465.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Adverse effects.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:36 [ 0 => array:3 [ "identificador" => "bib0185" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Dony" 1 => "V. Dewinde" 2 => "B. Vanderick" 3 => "O. Cuignet" 4 => "P. Gautier" 5 => "E. Legrand" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2000" "volumen" => "91" "paginaInicial" => "1489" "paginaFinal" => "1492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11094006" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0190" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anaesthetic agents for advanced regional anaesthesia: a North American perspective" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.C. Buckenmaier 3rd" 1 => "L.L. Bleckner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2005" "volumen" => "65" "paginaInicial" => "745" "paginaFinal" => "759" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15819588" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0195" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.W. Clarkson" 1 => "L.M. Hondeghem" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "1985" "volumen" => "62" "paginaInicial" => "396" "paginaFinal" => "405" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2580463" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0200" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine: a review of its pharmacology and use as a local anaesthetic" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.H. Foster" 1 => "A. Markham" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2000" "volumen" => "59" "paginaInicial" => "551" "paginaFinal" => "579" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10776835" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0205" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine: a long acting local anaesthetic, with less cardiac and neurotoxicity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.G. Arias" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Update Anaesth" "fecha" => "2002" "paginaInicial" => "14" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0210" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anaesthesia with ropivacaine 5<span class="elsevierStyleHsp" style=""></span>mg/ml in glucose 10<span class="elsevierStyleHsp" style=""></span>mg/ml or 50<span class="elsevierStyleHsp" style=""></span>mg/ml" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.B. Whiteside" 1 => "J.A.W. Wildsmith" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2001" "volumen" => "86" "paginaInicial" => "241" "paginaFinal" => "244" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11573667" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0215" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intrathecal anesthesia: ropivacaine versus bupivacaine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Malinovsky" 1 => "F. Charles" 2 => "O. Kick" 3 => "J.Y. Lepage" 4 => "M. Malinge" 5 => "A. Cozian" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2000" "volumen" => "91" "paginaInicial" => "1457" "paginaFinal" => "1460" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11094000" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0220" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intrathecal use of ropivacaine: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Wille" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Anaesthesiol Belg" "fecha" => "2004" "volumen" => "55" "paginaInicial" => "251" "paginaFinal" => "259" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15515303" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0225" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bupivacaine, levobupivacaine and ropivacaine: are they clinically different" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Casati" 1 => "M. Putzu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Best Pract Res Clin Anaesthesiol" "fecha" => "2005" "volumen" => "19" "paginaInicial" => "247" "paginaFinal" => "268" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15966496" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0230" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimum effective local anaesthetic dose of isobaric levobupivacaine and ropivacaine administered via a spinal catheter for hip replacement surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Sell" 1 => "K.T. Olkkola" 2 => "J. Jalonen" 3 => "R. Aantaa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aei015" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2005" "volumen" => "94" "paginaInicial" => "239" "paginaFinal" => "242" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15516345" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0235" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Casati" 1 => "E. Moizo" 2 => "C. Marchetti" 3 => "F. Vinciguerra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/01.ANE.0000132972.61498.F1" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2004" "volumen" => "99" "paginaInicial" => "1387" "paginaFinal" => "1392" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15502035" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0240" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anesthesia with hyperbaric levobupivacaine and ropivacaine for outpatient knee arthroscopy: a prospective, randomized, double-blind study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Cappelleri" 1 => "G. Aldegheri" 2 => "G. Danelli" 3 => "C. Marchetti" 4 => "M. Nuzzi" 5 => "G. Iannandrea" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/01.ANE.0000155265.79673.56" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2005" "volumen" => "101" "paginaInicial" => "77" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15976210" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0245" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anesthesia: comparison of plain ropivacaine, bupivacaine and levobupivacaine for lower abdominal surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Mantouvalou" 1 => "S. Ralli" 2 => "H. Arnaoutoglou" 3 => "G. Tziris" 4 => "G. Papadopoulos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Anaesthesiol Belg" "fecha" => "2008" "volumen" => "59" "paginaInicial" => "65" "paginaFinal" => "71" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18652102" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0250" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidural analgesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P.R. Bromage" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "fecha" => "1978" "paginaInicial" => "144" "editorial" => "WB Saunders" "editorialLocalizacion" => "Philadelphia" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0255" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G. Aberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Pharmacol Toxicol" "fecha" => "1972" "volumen" => "31" "paginaInicial" => "444" "paginaFinal" => "450" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0260" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine: a review of its use in regional anaesthesia and pain management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Sanford" 1 => "G.M. Keating" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2165/11203250-000000000-00000" "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2010" "volumen" => "70" "paginaInicial" => "761" "paginaFinal" => "791" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20394458" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0265" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relative potencies of bupivacaine, levobupivacaine, and ropivacaine for neonatal spinal anaesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Frawley" 1 => "K.R. Smith" 2 => "P. Ingelmo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aep259" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2009" "volumen" => "103" "paginaInicial" => "731" "paginaFinal" => "738" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19767606" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0270" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine base and levobupivacaine hydrochloride" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.H. Rosenberg" 1 => "S.A. Schug" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aei525" "Revista" => array:5 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2005" "volumen" => "94" "paginaInicial" => "544" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15758086" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0275" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The median effective dose of bupivacaine, levobupivacaine, and ropivacaine after intrathecal injection in lower limb surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y.Y. Lee" 1 => "W.D. Ngan Kee" 2 => "S.Y. Fong" 3 => "J.T.C. Liu" 4 => "T. Gin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/ane.0b013e3181b1912b" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2009" "volumen" => "109" "paginaInicial" => "1331" "paginaFinal" => "1334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19762766" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0280" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimum local anaesthetic dose (MLAD) of intrathecal levobupivacaine and ropivacaine for Caesarean section" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Parpaglioni" 1 => "M.G. Frigo" 2 => "A. Lemma" 3 => "M. Sebastiani" 4 => "G. Barbati" 5 => "D. Celleno" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2044.2005.04380.x" "Revista" => array:6 [ "tituloSerie" => "Anaesthesia" "fecha" => "2006" "volumen" => "61" "paginaInicial" => "110" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16430561" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0285" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intrathecal ropivacaine for ambulatory surgery: a comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.E. Gautier" 1 => "M. De Kock" 2 => "A.V. Steenberge" 3 => "N. Poth" 4 => "B. Lahaye-Goffart" 5 => "L. Fanard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "1999" "volumen" => "91" "paginaInicial" => "1239" "paginaFinal" => "1245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10551572" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0290" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Leone" 1 => "S.D. Cianni" 2 => "A. Casati" 3 => "G. Fanelli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Biomed" "fecha" => "2008" "volumen" => "79" "paginaInicial" => "92" "paginaFinal" => "105" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18788503" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0295" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine versus racemic bupivacaine for spinal anesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Glaser" 1 => "P. Marhofer" 2 => "G. Zimpfer" 3 => "M.T. Heinz" 4 => "C. Sitzwohl" 5 => "S. Kapral" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2002" "volumen" => "94" "paginaInicial" => "194" "paginaFinal" => "198" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11772827" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0300" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Urinary bladder scanning after day-case arthroscopy under spinal anaesthesia: comparison between lidocaine, ropivacaine, and levobupivacaine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.B. Breebaart" 1 => "M.P. Vercauteren" 2 => "V.L. Hoffmann" 3 => "H.A. Adriaensen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2003" "volumen" => "90" "paginaInicial" => "309" "paginaFinal" => "313" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12594142" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0305" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anaesthesia: comparison of plain ropivacaine 5<span class="elsevierStyleHsp" style=""></span>mg/ml with bupivacaine 5<span class="elsevierStyleHsp" style=""></span>mg/ml for major orthopaedic surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D.A. McNamee" 1 => "A.M. McClelland" 2 => "S. Scott" 3 => "K.R. Milligan" 4 => "L. Westman" 5 => "K.R.U. Gustafsson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2002" "volumen" => "89" "paginaInicial" => "702" "paginaFinal" => "706" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12393766" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0310" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levobupivacaine and bupivacaine in spinal anesthesia for transurethral endoscopic surgery" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "O. Vanna" 1 => "L. Chumsang" 2 => "S. Thongmee" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Med Assoc Thail" "fecha" => "2006" "volumen" => "89" "paginaInicial" => "1133" "paginaFinal" => "1139" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0315" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anesthesia for transurethral resection operations: levobupivacaine with or without fentanyl" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "O. Cuvas" 1 => "H. Basar" 2 => "A. Yeygel" 3 => "E. Turkyýlmaz" 4 => "M.M. Sunay" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Middle East J Anaesthesiol" "fecha" => "2010" "volumen" => "20" "paginaInicial" => "547" "paginaFinal" => "552" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20394252" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0320" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical characteristics of spinal levobupivacaine: hyperbaric compared with isobaric solution" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Sanansilp" 1 => "T. Trivate" 2 => "P. Chompubai" 3 => "S. Visalyaputra" 4 => "P. Suksopee" 5 => "L. Permpolprasert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Sci World J" "fecha" => "2012" "paginaInicial" => "1" "paginaFinal" => "7" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0325" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of injected volume and speed of injection on the spread of spinal anesthesia with isobaric amethocaine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.H. McClure" 1 => "D.T. Brown" 2 => "J.A.W. Wildsmith" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Anaesth" "fecha" => "1982" "volumen" => "54" "paginaInicial" => "917" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7115603" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0330" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal ropivacaine for cesarean delivery: a comparison of hyperbaric and plain solutions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "K.S. Khaw" 1 => "W.D. Ngan Kee" 2 => "M. Wong" 3 => "Ng. Floria" 4 => "A. Lee" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2002" "volumen" => "94" "paginaInicial" => "680" "paginaFinal" => "685" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11867397" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0335" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G.A. McLeod" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aeh094" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2004" "volumen" => "92" "paginaInicial" => "547" "paginaFinal" => "551" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14766715" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0340" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal anesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Tsai" 1 => "R. Greengrass" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Textbook of regional anesthesia and acute pain management" "paginaInicial" => "194" "paginaFinal" => "221" "edicion" => "1st ed." "serieFecha" => "2007" ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0345" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spinal, epidural, and caudal anesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D.L. Brown" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Miller's anesthesia" "paginaInicial" => "1611" "paginaFinal" => "1638" "edicion" => "7th ed." "serieFecha" => "2009" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0350" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Isobaric 0.5% bupivacaine and 0.5% ropivacaine in spinal anesthesia for orthopedic surgery – a comparative study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Delfino" 1 => "S. Pontes" 2 => "D. Gondim" 3 => "N.B. Vale" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Bras Anestesiol" "fecha" => "1999" "volumen" => "49" "paginaInicial" => "160" "paginaFinal" => "164" ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0355" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the effects of intrathecal ropivacaine, levobupivacaine, and bupivacaine for Caesarean section" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Gautier" 1 => "M. De Kock" 2 => "L. Huberty" 3 => "T. Demir" 4 => "M. Izydorczic" 5 => "B. Vanderick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2003" "volumen" => "91" "paginaInicial" => "684" "paginaFinal" => "689" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14570791" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0360" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and risk factors for side effects of spinal anesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.L. Carpenter" 1 => "R.A. Caplan" 2 => "D.L. Brown" 3 => "C. Stephenson" 4 => "R. Wu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "1992" "volumen" => "76" "paginaInicial" => "906" "paginaFinal" => "916" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1599111" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22562087/0000004400000002/v1_201604260026/S225620871600016X/v1_201604260026/en/main.assets" "Apartado" => array:4 [ "identificador" => "951" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific and Technological Research" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22562087/0000004400000002/v1_201604260026/S225620871600016X/v1_201604260026/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225620871600016X?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 16 | 0 | 16 |
2024 October | 95 | 7 | 102 |
2024 September | 134 | 8 | 142 |
2024 August | 90 | 5 | 95 |
2024 July | 126 | 12 | 138 |
2024 June | 100 | 14 | 114 |
2024 May | 60 | 4 | 64 |
2024 April | 60 | 12 | 72 |
2024 March | 89 | 15 | 104 |
2024 February | 102 | 12 | 114 |
2024 January | 95 | 20 | 115 |
2023 December | 72 | 22 | 94 |
2023 November | 101 | 18 | 119 |
2023 October | 106 | 15 | 121 |
2023 September | 66 | 5 | 71 |
2023 August | 43 | 4 | 47 |
2023 July | 48 | 7 | 55 |
2023 June | 63 | 10 | 73 |
2023 May | 105 | 9 | 114 |
2023 April | 57 | 10 | 67 |
2023 March | 56 | 11 | 67 |
2023 February | 48 | 18 | 66 |
2023 January | 35 | 10 | 45 |
2022 December | 38 | 5 | 43 |
2022 November | 37 | 4 | 41 |
2022 October | 42 | 11 | 53 |
2022 September | 28 | 21 | 49 |
2022 August | 38 | 13 | 51 |
2022 July | 37 | 14 | 51 |
2022 June | 40 | 18 | 58 |
2022 May | 25 | 13 | 38 |
2022 April | 44 | 15 | 59 |
2022 March | 34 | 11 | 45 |
2022 February | 16 | 9 | 25 |
2022 January | 24 | 13 | 37 |
2021 December | 20 | 12 | 32 |
2021 November | 16 | 20 | 36 |
2021 October | 46 | 12 | 58 |
2021 September | 59 | 23 | 82 |
2021 August | 56 | 21 | 77 |
2021 July | 30 | 16 | 46 |
2021 June | 32 | 16 | 48 |
2021 May | 31 | 11 | 42 |
2021 April | 40 | 12 | 52 |
2021 March | 23 | 5 | 28 |
2021 February | 14 | 10 | 24 |
2021 January | 14 | 11 | 25 |
2020 December | 10 | 10 | 20 |
2020 November | 10 | 10 | 20 |
2020 October | 9 | 9 | 18 |
2020 September | 13 | 6 | 19 |
2020 August | 14 | 10 | 24 |
2020 July | 16 | 11 | 27 |
2020 June | 5 | 6 | 11 |
2020 May | 8 | 6 | 14 |
2020 April | 6 | 4 | 10 |
2020 March | 4 | 4 | 8 |
2020 February | 9 | 2 | 11 |
2020 January | 8 | 3 | 11 |
2019 December | 12 | 9 | 21 |
2019 November | 4 | 2 | 6 |
2019 October | 5 | 2 | 7 |
2019 September | 2 | 3 | 5 |
2019 July | 1 | 3 | 4 |
2019 June | 2 | 3 | 5 |
2019 May | 0 | 13 | 13 |
2019 April | 1 | 0 | 1 |
2019 January | 1 | 0 | 1 |
2018 September | 1 | 0 | 1 |
2018 June | 3 | 3 | 6 |
2018 May | 26 | 10 | 36 |
2018 April | 36 | 6 | 42 |
2018 March | 26 | 10 | 36 |
2018 February | 16 | 5 | 21 |
2018 January | 23 | 8 | 31 |
2017 December | 23 | 6 | 29 |
2017 November | 17 | 7 | 24 |
2017 October | 18 | 12 | 30 |
2017 September | 22 | 4 | 26 |
2017 August | 10 | 8 | 18 |
2017 July | 23 | 5 | 28 |
2017 June | 26 | 16 | 42 |
2017 May | 36 | 12 | 48 |
2017 April | 35 | 9 | 44 |
2017 March | 12 | 8 | 20 |
2017 February | 11 | 2 | 13 |
2017 January | 14 | 3 | 17 |
2016 December | 40 | 9 | 49 |
2016 November | 25 | 6 | 31 |
2016 October | 45 | 5 | 50 |
2016 September | 30 | 6 | 36 |
2016 August | 28 | 7 | 35 |
2016 July | 28 | 9 | 37 |
2016 May | 4 | 33 | 37 |